Optimus Drugs Private Limited - Company Profile

Q: Who are the current directors of Optimus Drugs Private Limited?

The current directors of Optimus Drugs Private Limited are Srinivasareddy Desireddy, Santosh Kumar Mahil, Sumit Mohan Nadgir, Durga Prasad Reddy Avula, Uma Rao, Ritali Patro Patro Tangudu.

It is a pharma private limited company based in Shaikpet, Telangana, India, established in 2003.

2003 Shaikpet, Telangana, India Active

Last Updated: January 05, 2026

Access Report

About Optimus Drugs Private Limited

Optimus Drugs Private Limited, a active private limited company, was established on 02 December 2003 in Shaikpet, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2003PTC042155. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹410.00 Cr and a paid-up capital of ₹35.14 Cr.

Formerly known as Surya Kiran Labs Private Limited. It upholds a compliant status. Employing 895 professional, Its leadership includes Srinivasareddy Desireddy (Director), Santosh Kumar Mahil (Additional Director), Sumit Mohan Nadgir (Additional Director). Past directors included Prabhat Kumar Kulshershta, Srinivasareddy Desireddy, Ashwin Savio Trinidad. It holds ₹188.61 Cr open charges and ₹167.44 Cr settled loans. Its latest AGM occurred on 31 January 2025, with the balance sheet filed on 31 March 2024. It is based at 7Th Floor, Maximus Towers, 2A,, Raheja Mindspace It Park, Hitec City,, Shaikpet, Telangana, 500081.

Company Details

CIN/LLPIN
U24239TG2003PTC042155
Registration Number
042155
Incorporation Date
02 December 2003
Authorized Capital
₹410.00 Cr
Paid-Up Capital
₹35.14 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 410.00 Cr as on 05-01-2026
Paid Up Capital ₹ 35.14 Cr as on 05-01-2026
Company Age 22 Year, 3 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 188.61 Cr as on 05-01-2026
Satisfied Charges ₹ 167.44 Cr as on 05-01-2026
Revenue Growth **** 1.98% (FY 2023)
Profit Growth **** -109.56% (FY 2023)
Ebitda **** 22.97% (FY 2023)
Net Worth 119.21% (FY 2023)
Total Assets **** 73.35% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Optimus Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Optimus Drugs Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Srinivasareddy Desireddy	Director	30 Mar 2006	Current
Santosh Kumar Mahil	Additional Director	26 Jun 2025	Current
Sumit Mohan Nadgir	Additional Director	01 Apr 2025	Current
Durga Prasad Reddy Avula	Director	22 Sep 2022	Current
Uma Rao	Director	09 May 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Nov 2012	Past
Pramod Abcsdd	Managing Director	22 Sep 2022	Past
Pramod Abcsdd	Additional Director	22 Sep 2022	Past
Pramod Abcsdd	Additional Director	20 Oct 2023	Past
Pramod Abcsdd	Additional Director	26 Jun 2025	Past
Pramod Abcsdd	Additional Director	23 Dec 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Optimus Drugs.

Optimus Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.98% increase. The company also saw a substantial fall in profitability, with a 109.56% decrease in profit. The company's net worth Soared by an impressive increase of 119.21%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

1.98%

*******

Revenue from Operations

*******

1.40%

*******

Total Assets

*******

73.35%

*******

Profit or Loss

*******

-109.56%

*******

Net Worth

*******

119.21%

*******

EBITDA

*******

22.97%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Optimus Drugs?

In 2023, Optimus Drugs had a promoter holding of 99.98% and a public holding of 0.02%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,886,100,000.00

Satisfied Charges

₹1,674,415,552.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 96.00 Cr
Others : 64.00 Cr
Axis Bank Limited : 28.61 Cr

Latest Charge Details

Date	Lender	Amount	Status
11 Nov 2022	Axis Bank Limited	₹3.61 Cr	Open
10 May 2022	Hdfc Bank Limited	₹1.00 Cr	Open
16 Sep 2017	Hdfc Bank Limited	₹55.00 Cr	Open
15 Sep 2017	Hdfc Bank Limited	₹40.00 Cr	Open
25 Jun 2015	Others	₹64.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Optimus Drugs?

Optimus Drugs has a workforce of 895 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Optimus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimus Drugs's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Optimus Drugs

Recent Activity within the Organization

Director Appointment

Santosh Kumar Mahil was appointed as a Additional Director was appointed as a Additional Director on 26 Jun 2025 & has been associated with this company since 8 months 9 days . was recorded as a recent event.
26 Jun 2025
Director Appointment

Sumit Mohan Nadgir was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 11 months 4 days . was recorded as a recent event.
01 Apr 2025
Annual General Meeting

Progress on Optimus Drugs Private Limited last Annual general meeting of members was held on 31 Jan 2025 as per latest MCA records. was documented.
31 Jan 2025
Director Appointment

Uma Rao was appointed as a Director was appointed as a Director on 09 May 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
09 May 2024
Balance Sheet

The activity Optimus Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
31 Mar 2024
Charges

The activity A charge with Others of Rs. 64.00 Cr registered on 25 Jun 2015 with Charge ID 10577123 was modified on 10 Nov 2023. was completed.
10 Nov 2023

Explore recent activity and updates - View Recent Activity